Descricao
Indicacoes
MCL CLL SLL
Mecanismo de acao
BTK ACP-5862 BTK , BTK BTK B BCR B ,BTK B
Farmacologia
12.1 Como funciona BTK ACP-5862 BTK , BTK BTK B BCR B ,BTK B
Dosagem
2.1 CALQUENCE CALQUENCE CALQUENCE 3 , , CALQUENCE
Precaucoes
5.1 CALQUENCE , ,2055 CALQUENCE 29% 3 , 18%, 14% [ (6.1)] 3 4 , 8% CALQUENCE EB (PML)
Interacoes medicamentosas
7.1 CALQUENCE CYP3A • CALQUENCE CYP3A [ (12.3)] • • CALQUENCE CYP3A • , , CALQUENCE[ (2.2)]
Reacoes adversas
• [ Precaucoes(5.1)] • [ Precaucoes(5.2)] • [ Precaucoes(5.3)] • [ Precaucoes(5.4)] • [ Precaucoes(5.5)] • , (DILI)[ Precaucoes(5.6)] 6.1 , , ……
Armazenamento
NDC 60 60 100 , , “ACA 100 mg” 0310-0512-60 20°C-25°C (68°F-77°F) 15°C-30°C (59°F-86°F) [ USP ]
